DexCom, Inc. DXCM
Set alert
84.76 USD +2.47 +3.00%
At close
86.40 +1.64 +1.93%
Pre-market · Nov 3, 8:16 AM ET
82.58 Day range 85.19
54.11 52-week range 92.59
- YTD
- +27.71%
- 1 year
- +40.26%
- Open
- 82.94
- Prev close
- 82.29
- Mkt cap
- 31.61B
- Vol
- 4.06M
- Avg vol
- 4.43M
- EPS
- 2.54
- P/E
- 33.37
- Div yield
- 0.00%
More statistics
- Low
- 82.58
- High
- 85.19
- Forward P/E
- 27.04
- Beta
- 1.44
- Short ratio
- 3.91
- Inst. own
- 107.83%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2027
- 50-d avg
- 85.82
- 200-d avg
- 74.56
- 1y target
- 98.15
MAX chart
Signals (82)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 1, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | Feb 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 1, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 1, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
Newest 20 of 82.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 98.15 +15.8% upside
Now 84.76
- Target (low)
- 79.00
- Target (mean)
- 98.15
- Target (high)
- 120.00
Ratings (0m) 29 26 buy · 3 hold · 0 sell
- Strong buy4
- Buy22
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 29
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.717 | 0.67 – 0.771 | 0.68 | +5.4% | 1.38B | +9.9% | 21 |
| Next quarter | 0.63716 | 0.57 – 0.74 | 0.56 | +13.8% | 1.31B | +10.1% | 17 |
| Current year | 2.70 | 2.45 – 2.78 | 2.09 | +29.2% | 5.23B | +12.1% | 25 |
| Next year | 3.13 | 2.76 – 3.46 | 2.70 | +16.1% | 5.77B | +10.4% | 25 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | StoneX | Maintained | Buy | Buy |
| Oct 12, 2026 | BTIG | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Initiated | — | Overweight |
| Oct 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 18, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 18, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Aug 4, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 31, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 31, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jul 31, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 31, 2026 | Stifel | Maintained | Buy | Buy |
| Jul 31, 2026 | Benchmark | Maintained | Buy | Buy |
| Jul 31, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 31, 2026 | BTIG | Maintained | Buy | Buy |
| Jul 16, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 23, 2026 | Deutsche Bank | Initiated | Buy | Buy |
| Jun 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 10, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jun 9, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 5, 2026 | Stifel | Maintained | Buy | Buy |
| May 28, 2026 | Citigroup | Maintained | Buy | Buy |
